GSK Investigational Site

Danville, Virginia 24549

1 studies enrolling now · 13 studies all time

What they study most

Asthma, Bipolar Disorder, Bowel Dysfunction, Constipation, Crohn's Disease, Epilepsy, Tonic-Clonic, Hepatitis A, Hypertrophy, Left Ventricular, Irritable Bowel Syndrome (IBS), Irritable Colon, Systemic Lupus Erythematosus

Studies at this site

• A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) — Recruiting now
• Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry — Completed
• Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months — Completed
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug — Completed
• Study Of Allergic Rhinitis In Patients Who Also Have Asthma — Completed
• The CLEVER Study - Coreg And Left Ventricular Mass Regression — Completed
• GSK BHR Study (Sont - Second Study) — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed